• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎中呼吸机相关性肺炎的防治

Prevention and treatment of ventilator-associated pneumonia in COVID-19.

作者信息

Deng Jiayi, Li Fanglin, Zhang Ningjie, Zhong Yanjun

机构信息

Department of Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.

Department of Hematology, The Third Xiangya Hospital, Central South University, Changsha, China.

出版信息

Front Pharmacol. 2022 Oct 19;13:945892. doi: 10.3389/fphar.2022.945892. eCollection 2022.

DOI:10.3389/fphar.2022.945892
PMID:36339583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9627032/
Abstract

Ventilator-associated pneumonia (VAP) is the most common acquired infection in the intensive care unit. Recent studies showed that the critical COVID-19 patients with invasive mechanical ventilation have a high risk of developing VAP, which result in a worse outcome and an increasing economic burden. With the development of critical care medicine, the morbidity and mortality of VAP remains high. Especially since the outbreak of COVID-19, the healthcare system is facing unprecedented challenges. Therefore, many efforts have been made in effective prevention, early diagnosis, and early treatment of VAP. This review focuses on the treatment and prevention drugs of VAP in COVID-19 patients. In general, prevention is more important than treatment for VAP. Prevention of VAP is based on minimizing exposure to mechanical ventilation and encouraging early release. There is little difference in drug prophylaxis from non-COVID-19. In term of treatment of VAP, empirical antibiotics is the main treatment, special attention should be paid to the antimicrobial spectrum and duration of antibiotics because of the existence of drug-resistant bacteria. Further studies with well-designed and large sample size were needed to demonstrate the prevention and treatment of ventilator-associated pneumonia in COVID-19 based on the specificity of COVID-19.

摘要

呼吸机相关性肺炎(VAP)是重症监护病房中最常见的获得性感染。最近的研究表明,接受有创机械通气的危重型新冠患者发生VAP的风险很高,这会导致更差的预后和不断增加的经济负担。随着重症医学的发展,VAP的发病率和死亡率仍然很高。特别是自新冠疫情爆发以来,医疗系统面临着前所未有的挑战。因此,在VAP的有效预防、早期诊断和早期治疗方面已经做出了许多努力。这篇综述聚焦于新冠患者VAP的治疗和预防药物。一般来说,对于VAP预防比治疗更重要。VAP的预防基于尽量减少机械通气暴露并鼓励尽早脱机。药物预防与非新冠患者相比差异不大。在VAP的治疗方面,经验性使用抗生素是主要治疗方法,但由于存在耐药菌,应特别注意抗生素的抗菌谱和使用时长。基于新冠的特殊性,需要进一步开展设计良好且样本量较大的研究来论证新冠患者呼吸机相关性肺炎的防治。

相似文献

1
Prevention and treatment of ventilator-associated pneumonia in COVID-19.新型冠状病毒肺炎中呼吸机相关性肺炎的防治
Front Pharmacol. 2022 Oct 19;13:945892. doi: 10.3389/fphar.2022.945892. eCollection 2022.
2
Ventilator-associated pneumonia complicating the acute respiratory distress syndrome.呼吸机相关性肺炎并发急性呼吸窘迫综合征。
Semin Respir Crit Care Med. 2001 Jun;22(3):317-26. doi: 10.1055/s-2001-15788.
3
Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS.COVID-19 相关 ARDS 患者中早期使用类固醇与呼吸机相关性肺炎。
Crit Care. 2022 Aug 2;26(1):233. doi: 10.1186/s13054-022-04097-8.
4
Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia and Ventilator-Associated Tracheobronchitis in COVID-19.新型冠状病毒肺炎(COVID-19)中的医院获得性肺炎/呼吸机相关性肺炎及呼吸机相关性气管支气管炎
Semin Respir Crit Care Med. 2022 Apr;43(2):243-247. doi: 10.1055/s-0041-1740334. Epub 2022 Jan 18.
5
Epidemiology of ventilator-associated pneumonia in ICU COVID-19 patients: an alarming high rate of multidrug-resistant bacteria.重症监护病房中感染新型冠状病毒肺炎患者的呼吸机相关性肺炎流行病学:多重耐药菌感染率高得惊人
J Anesth Analg Crit Care. 2022 Aug 19;2(1):36. doi: 10.1186/s44158-022-00065-4.
6
Antibiotics for ventilator-associated pneumonia.用于呼吸机相关性肺炎的抗生素
Cochrane Database Syst Rev. 2016 Oct 20;10(10):CD004267. doi: 10.1002/14651858.CD004267.pub4.
7
Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.诗里拉吉医院成人医院获得性肺炎和呼吸机相关性肺炎:病因、临床结局及抗菌药物耐药性的影响
J Med Assoc Thai. 2010 Jan;93 Suppl 1:S126-38.
8
Ventilator-associated pneumonia related to extended-spectrum beta-lactamase producing Enterobacterales during severe acute respiratory syndrome coronavirus 2 infection: risk factors and prognosis.严重急性呼吸综合征冠状病毒 2 感染期间与产超广谱β-内酰胺酶肠杆菌科相关的呼吸机相关性肺炎:危险因素和预后。
Crit Care. 2024 Apr 20;28(1):131. doi: 10.1186/s13054-024-04906-2.
9
Risk Factors of Ventilator-Associated Pneumonia in Critically III Patients.重症患者呼吸机相关性肺炎的危险因素
Front Pharmacol. 2019 May 9;10:482. doi: 10.3389/fphar.2019.00482. eCollection 2019.
10
Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease.病毒相关性急性呼吸窘迫综合征与非冠状病毒 19 疾病患者呼吸机相关性肺炎和侵袭性肺曲霉病的风险。
Crit Care. 2020 Dec 18;24(1):699. doi: 10.1186/s13054-020-03417-0.

引用本文的文献

1
Effect of sivelestat sodium on the incidence of ventilator-associated pneumonia in patients with sepsis and ARDS.西维来司他钠对脓毒症和急性呼吸窘迫综合征患者呼吸机相关性肺炎发生率的影响。
Front Med (Lausanne). 2025 Aug 6;10:1618914. doi: 10.3389/fmed.2025.1618914. eCollection 2025.
2
A Nomogram for Predicting Survival in Patients with SARS-CoV-2 Omicron Variant Pneumonia Based on Admission Data.基于入院数据预测新冠病毒奥密克戎变异株肺炎患者生存情况的列线图
Infect Drug Resist. 2025 Apr 25;18:2093-2104. doi: 10.2147/IDR.S509178. eCollection 2025.
3
Mechanical Ventilator-Associated Pneumonia in the COVID-19 Pandemic Era: A Critical Challenge in the Intensive Care Units.新冠疫情时代的机械通气相关性肺炎:重症监护病房面临的严峻挑战
Antibiotics (Basel). 2025 Jan 3;14(1):28. doi: 10.3390/antibiotics14010028.

本文引用的文献

1
Prevalence of Micronutrient Deficiencies in Patients Hospitalized with COVID-19: An Observational Cohort Study.COVID-19 住院患者微量营养素缺乏症的患病率:一项观察性队列研究。
Nutrients. 2022 Apr 29;14(9):1862. doi: 10.3390/nu14091862.
2
Attributable Mortality of Ventilator-associated Pneumonia Among Patients with COVID-19.COVID-19 患者呼吸机相关性肺炎的归因死亡率。
Am J Respir Crit Care Med. 2022 Jul 15;206(2):161-169. doi: 10.1164/rccm.202202-0357OC.
3
Enhanced DNA and RNA pathogen detection via metagenomic sequencing in patients with pneumonia.通过宏基因组测序增强对肺炎患者DNA和RNA病原体的检测
J Transl Med. 2022 May 4;20(1):195. doi: 10.1186/s12967-022-03397-5.
4
Role of Early Enteral Nutrition in Mechanically Ventilated COVID-19 Patients.早期肠内营养在机械通气的新型冠状病毒肺炎患者中的作用
Crit Care Explor. 2022 Apr 18;4(4):e0683. doi: 10.1097/CCE.0000000000000683. eCollection 2022 Apr.
5
The Use of Proton Pump Inhibitors and COVID-19: A Systematic Review and Meta-Analysis.质子泵抑制剂与新型冠状病毒肺炎:一项系统评价与荟萃分析
Trop Med Infect Dis. 2022 Feb 28;7(3):37. doi: 10.3390/tropicalmed7030037.
6
An ionophore breaks the multi-drug-resistance of .离子载体可打破……的多药耐药性。 (原文句子不完整,翻译时根据已有内容尽量准确表达)
Microb Cell. 2022 Feb 15;9(3):69-71. doi: 10.15698/mic2022.03.772. eCollection 2022 Mar 7.
7
Therapeutic use of intravenous selenium in respiratory and immunological diseases: evidence based on reviews focused on clinical trials.静脉注射硒在呼吸系统和免疫性疾病中的治疗应用:基于聚焦临床试验的综述证据
Adv Respir Med. 2022 Jan 31. doi: 10.5603/ARM.a2022.0018.
8
Multiple Secondary Healthcare-Associated Infections Due to Carbapenem-Resistant Organisms in a Critically Ill COVID-19 Patient on Extensively Prolonged Venovenous Extracorporeal Membrane Oxygenation Support-A Case Report.一名危重症新型冠状病毒肺炎患者在接受长时间体外膜肺氧合支持治疗期间发生多起耐碳青霉烯类病原体所致的继发性医疗相关感染——病例报告
Microorganisms. 2021 Dec 23;10(1):19. doi: 10.3390/microorganisms10010019.
9
How common is ventilator-associated pneumonia after coronavirus disease 2019?新冠肺炎后呼吸机相关性肺炎的发病率有多高?
Curr Opin Infect Dis. 2022 Apr 1;35(2):170-175. doi: 10.1097/QCO.0000000000000817.
10
Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions.评价新冠病毒普通重症监护病房患者气管内抽吸培养物中分离出的细菌,并与大流行前的情况相比,评估其抗生素耐药谱。
Microb Pathog. 2022 Mar;164:105409. doi: 10.1016/j.micpath.2022.105409. Epub 2022 Jan 15.